NCT03089034 (SCOPAH) is a clinical trial in Chronic Heart Failure, sponsored by Duke-NUS Graduate Medical School.

Who is sponsoring NCT03089034?

NCT03089034 is sponsored by Duke-NUS Graduate Medical School.

What condition does NCT03089034 study?

NCT03089034 studies Chronic Heart Failure.

Is NCT03089034 still recruiting?

NCT03089034 is currently active, enrolled. Last updated 5 February 2025.

Last reviewed 2025-02-05 · How we verify

NCT03089034: SCOPAH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Singapore Cohort of Patients with Advanced Heart Failure

Active, enrolled Last updated 5 February 2025

What this trial tests

trial in Chronic Heart Failure in 300 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

24 July 2017

Primary endpoint
31 October 2025

31 October 2025

Quick facts

Lead sponsor	Duke-NUS Graduate Medical School
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	300
Start date	24 July 2017
Primary completion	31 October 2025
Estimated completion	31 October 2025
Sites	1 location across Singapore

Conditions studied

Chronic Heart Failure — all drugs for Chronic Heart Failure →

Sponsor

Duke-NUS Graduate Medical School

Who can join

21 and older, any sex, with Chronic Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic Heart Failure (CHF) is one of the leading causes of death in Singapore. Although it is well established that CHF patients in Singapore are less likely to be referred to palliative care services than cancer patients, little data is available on end-of-life (EOL) experience of advanced CHF patients in Singapore, including the inter-relationships between patient decision-making, quality of life trajectories, and health and cost consequences.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Study protocol for a cohort study of patients with advanced heart failure in Singapore.
Malhotra C, Foo R, Singh R, Ozdemir S, et al · · 2018 · cited 9× · PMID 30224389 · DOI 10.1136/bmjopen-2018-022248

Verify or expand the search:

Other recruiting trials for Chronic Heart Failure

Currently open trials in the same condition.

NCT07265349 — A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure · Phase 1, PHASE2 · recruiting
NCT07379840 — A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South K · recruiting
NCT07325942 — Effectiveness of Low -Versus High -Volume High -Intensity Interval Training in Patients With Chronic Heart Failure · NA · recruiting
NCT07434193 — Biventricular or Left Bundle Branch Pacing to Assess the Effect of Cardiac Resynchronization Therapy in Patients Undergo · NA · recruiting
NCT07405944 — Vericiguat and Reverse Remodeling Indices in Heart Failure · Phase 4 · recruiting

Other Duke-NUS Graduate Medical School trials

Trials by the same sponsor.

NCT07309367 — Web-based Advance Care Planning Intervention for Patients With Kidney Failure on Dialysis: Pilot Testing of 'My Voice' · NA · recruiting
NCT06817876 — Connecting Caregivers With Community Services: The Care Buddy Platform · NA · recruiting
NCT06440421 — Understanding Food Choices in Bahrain Using Bahrain e-Mart · NA · completed
NCT06102954 — A Multi-domain and Multi-component Falls Intervention Program for Community- Dwelling Older Adults: SAFE-TECH · NA · recruiting
NCT06155981 — Coca-Cola Zero (®) Consumption on Night-call Inpatient Course and Mortality · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03089034 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke-NUS Graduate Medical School
Last refreshed: 5 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03089034.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing